Healthcare Costs Among Patients With CML Receiving Dasatinib or Nilotinib in a Commercial and Medicare Population
Condition(s):Chronic Myeloid Leukemia (CML)Last Updated:July 7, 2015Completed
Hide Studies Not Open or Pending
Condition(s):Chronic Myeloid Leukemia (CML)Last Updated:July 7, 2015Completed
Condition(s):Chronic Myeloid LeukemiaLast Updated:February 28, 2017Completed
Condition(s):Chronic Myeloid LeukemiaLast Updated:August 29, 2012Completed
Condition(s):Chronic Myeloid LeukemiaLast Updated:November 28, 2005Terminated
Condition(s):Chronic Myeloid LeukemiaLast Updated:December 22, 2005Completed
Condition(s):Chronic Phase Chronic Myeloid LeukemiaLast Updated:December 21, 2022Completed
Condition(s):Chronic Myeloid LeukemiaLast Updated:April 13, 2020Completed
Condition(s):CHRONIC MYELOGENOUS LEUKAEMIA IN ACCELERATED PHASE; CHRONIC MYELOGENOUS LEUKAEMIA IN MYELOID BLAST CRISISLast Updated:August 7, 2020Recruiting
Condition(s):Chronic Myeloid LeukemiaLast Updated:March 15, 2024Recruiting
Condition(s):Chronic Myeloid LeukemiaLast Updated:November 29, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.